PROJECT
PARTNER
Takeda
Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries and regions. For more information, visit https://www.takeda.com.
Role in the Facilitate Project
Takeda will contribute to WP2 (Legal and Privacy framework), WP3 (Ethics, standardization and regulatory framework), WP4 (Platform architecture and clinical trial specification) and WP5 (Technology framework and interoperability tools). Takeda will act as EFPIA Lead for WP6 (Dissemination and communication)
